Citigroup Inc. diskutieren
Citigroup Inc.
WKN: A1H92V / Symbol: C / Name: Citigroup / Aktie / Banken / Large Cap /
101,24 €
0,92 %
Citigroup Inc. (NYSE: C) had its price target lowered by analysts at Truist Financial Co. from $85.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target lowered by analysts at Truist Financial Co. from $84.00 to $79.00. They now have a "buy" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $77.00 price target on the stock, down previously from $83.00.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its "outperform" rating re-affirmed by analysts at Keefe, Bruyette & Woods. They now have a $92.00 price target on the stock, down previously from $96.00.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target lowered by analysts at Royal Bank of Canada from $85.00 to $78.00. They now have an "outperform" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Oppenheimer Holdings Inc. from $91.00 to $94.00. They now have an "outperform" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $75.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Morgan Stanley from $90.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its "buy" rating re-affirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Bank of America Corporation from $89.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $85.00 to $96.00. They now have a "buy" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Morgan Stanley from $94.00 to $103.00. They now have an "overweight" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings, Inc..
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Truist Financial Corporation from $84.00 to $93.00. They now have a "buy" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Morgan Stanley from $103.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Barclays PLC from $95.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $107.00 to $123.00. They now have an "outperform" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Piper Sandler from $84.00 to $104.00. They now have an "overweight" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Truist Financial Corporation from $93.00 to $99.00. They now have a "buy" rating on the stock.
Ratings data for C provided by MarketBeat
Citigroup Inc. (NYSE: C) had its price target raised by analysts at Wells Fargo & Company from $110.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for C provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Agios Pharmaceuticals Inc. diskutieren